Cargando…

Anti-Osteogenic Effect of Danshensu in Ankylosing Spondylitis: An in Vitro Study Based on Integrated Network Pharmacology

Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by abnormal bone metabolism, with few effective treatments available. Danshensu [3-(3,4-dihydroxy-phenyl) lactic acid) is a bioactive compound from traditional Chinese medicine with a variety of pharmacologic effects. In the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiaxiao, Chen, Zexin, Liao, Hongbo, Zhong, Yanting, Hua, Junying, Su, Miaoling, Li, Jiahao, Xu, Jinrong, Cui, Liao, Cui, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656304/ https://www.ncbi.nlm.nih.gov/pubmed/34899327 http://dx.doi.org/10.3389/fphar.2021.772190

Ejemplares similares

Multi-target mechanism of Tripteryguim wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking
por: Zhang, Jing, et al.
Publicado: (2021)

Danshensu methyl ester enhances autophagy to attenuate pulmonary fibrosis by targeting lncIAPF–HuR complex
por: Zhu, Qi, et al.
Publicado: (2022)

Perioperative Management of Patients With Ankylosing Spondylitis Undergoing Spine Surgery
por: Zakaryan, Arman, et al.
Publicado: (2020)

Corrigendum: Danshensu methyl ester enhances autophagy to attenuate pulmonary fibrosis by targeting lncIAPF–HuR complex
por: Zhu, Qi, et al.
Publicado: (2022)

Salvianolic acid B and danshensu induce osteogenic differentiation of rat bone marrow stromal stem cells by upregulating the nitric oxide pathway
por: Zhang, Xinle, et al.
Publicado: (2017)

Sodium danshensu attenuates cerebral ischemia–reperfusion injury by targeting AKT1
por: Gao, Qing, et al.
Publicado: (2022)

Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study
por: Wu, Jialing, et al.
Publicado: (2020)

Dynamics of Adaptive Immune Cell and NK Cell Subsets in Patients With Ankylosing Spondylitis After IL-17A Inhibition by Secukinumab
por: Jiang, Yutong, et al.
Publicado: (2021)

A Danshensu-Tetramethylpyrazine Conjugate DT-010 Overcomes Multidrug Resistance in Human Breast Cancer
por: Zhou, Xinhua, et al.
Publicado: (2019)

Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool
por: Bao, Xiao-yi, et al.
Publicado: (2018)

Cytokines and regulatory T cells in ankylosing spondylitis
por: Liao, Hsien-Tzung, et al.
Publicado: (2023)

T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis
por: WANG, CHENGGONG, et al.
Publicado: (2015)

Associations of Platelet Count with Inflammation and Response to Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis
por: Qian, Hongyan, et al.
Publicado: (2020)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points
por: Su, Jinmei, et al.
Publicado: (2020)

Synergistic and Hepatoprotective Effect of Total Glucosides of Paeony on Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
por: Huang, Yao, et al.
Publicado: (2019)

The Trend of Targeted Therapies in Chinese Patients With Ankylosing Spondylitis: Results From a Real-Life Survey
por: Wen, Yiquan, et al.
Publicado: (2021)

CXCL12/CXCR4-Rac1–mediated migration of osteogenic precursor cells contributes to pathological new bone formation in ankylosing spondylitis
por: Cui, Haowen, et al.
Publicado: (2022)

Kimura's disease and ankylosing spondylitis: A case report
por: Chen, Anping, et al.
Publicado: (2020)

Preclinical Absorption, Distribution, Metabolism, and Excretion of Sodium Danshensu, One of the Main Water-Soluble Ingredients in Salvia miltiorrhiza, in Rats
por: Meng, Xiangguo, et al.
Publicado: (2019)

miR-150-5p inhibits osteogenic differentiation of fibroblasts in ankylosing spondylitis by targeting VDR
por: Li, Yuan, et al.
Publicado: (2022)

Imaging of ankylosing spondylitis
por: Østergaard, Mikkel
Publicado: (2012)

Alexithymia in ankylosing spondylitis
por: Karabıçak, Deniz, et al.
Publicado: (2021)

Exploring the Mechanism of Danshensu in the Treatment of Doxorubicin-Induced Cardiotoxicity Based on Network Pharmacology and Experimental Evaluation
por: Qi, Jia-ying, et al.
Publicado: (2022)

Celastrol inhibits prostaglandin E2-induced proliferation and osteogenic differentiation of fibroblasts isolated from ankylosing spondylitis hip tissues in vitro
por: Zou, Yu-Cong, et al.
Publicado: (2016)

Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease
por: Wang, Ruiwen, et al.
Publicado: (2021)

Effectiveness of Subcutaneous Tumor Necrosis Factor Inhibitors in Patients With Ankylosing Spondylitis: A Real-World Prospective Observational Cohort Study in China
por: Ji, Xiaojian, et al.
Publicado: (2019)

Osteogenic differentiation characteristics of hip joint capsule fibroblasts obtained from patients with ankylosing spondylitis
por: Jiang, Nan, et al.
Publicado: (2021)

HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis
por: Zhong, Zhenyu, et al.
Publicado: (2021)

HDAC1 regulates inflammation and osteogenic differentiation of ankylosing spondylitis fibroblasts through the Wnt-Smad signaling pathway
por: Zeng, Yong, et al.
Publicado: (2022)

Chemical Shift-Encoded MRI of Bone Metabolic Markers in Ankylosing Spondylitis
por: Ma, Li-ping, et al.
Publicado: (2022)

Adverse events of tumor necrosis factor alpha inhibitors for the treatment of ankylosing spondylitis: A meta-analysis of randomized, placebo-controlled trials
por: Feng, Haihuan, et al.
Publicado: (2023)

Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA
por: Sun, Tao, et al.
Publicado: (2023)

Update on the treatment of ankylosing spondylitis
por: Maksymowych, Walter P
Publicado: (2007)

Ankylosing spondylitis: yesterday and today.
por: Spencer, D G, et al.
Publicado: (1980)

Treat Ankylosing Spondylitis with Methazolamide
por: Chang, Xiaotian, et al.
Publicado: (2011)

Infliximab in the treatment of ankylosing spondylitis
por: Grainger, Rebecca, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_r3crpj34cia4e2cejfui4bo2rb